Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-21

FDA Approved: YCANTH — Original Application (Verrica Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved YCANTH (cantharidin) from Verrica Pharmaceuticals in an Original Application (NDA 212905) for the topical treatment of common warts (verruca vulgar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YCANTH (cantharidin)

Snippet

ORIG AP for YCANTH (CANTHARIDIN)